Krop Julie
Aquestive Therapeutics, Inc. · Director
Krop Julie is listed in filings as Director at Aquestive Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 24, 2026, including sale activity. Recent filings connect the profile to Aquestive Therapeutics, Inc. (AQST) and DiaMedica Therapeutics Inc. (DMAC). The current snapshot covers public activity from Nov 3, 2025 to Jun 24, 2026. Reported amounts are shown as $125.4K to $201.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $125k25k shares | SellJun 23, 2026 | $5.02 | $4.04 |